These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 8006647)
21. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Zeng K; Wang X; Xi Z; Yan Y Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Baulac M; Brodie MJ; Patten A; Segieth J; Giorgi L Lancet Neurol; 2012 Jul; 11(7):579-88. PubMed ID: 22683226 [TBL] [Abstract][Full Text] [Related]
23. Weight gain with valproate or carbamazepine--a reappraisal. Easter D; O'Bryan-Tear CG; Verity C Seizure; 1997 Apr; 6(2):121-5. PubMed ID: 9153724 [TBL] [Abstract][Full Text] [Related]
24. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Donati F; Gobbi G; Campistol J; Rapatz G; Daehler M; Sturm Y; Aldenkamp AP; Seizure; 2007 Dec; 16(8):670-9. PubMed ID: 17574448 [TBL] [Abstract][Full Text] [Related]
25. Valproate monotherapy in the management of generalized and partial seizures. Chadwick DW Epilepsia; 1987; 28 Suppl 2():S12-7. PubMed ID: 3121291 [TBL] [Abstract][Full Text] [Related]
26. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. Isojärvi JI; Laatikainen TJ; Pakarinen AJ; Juntunen KT; Myllylä VV N Engl J Med; 1993 Nov; 329(19):1383-8. PubMed ID: 8413434 [TBL] [Abstract][Full Text] [Related]
27. Lamotrigine versus carbamazepine monotherapy for epilepsy. Gamble CL; Williamson PR; Marson AG Cochrane Database Syst Rev; 2006 Jan; (1):CD001031. PubMed ID: 16437428 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. Perucca E CNS Drugs; 2002; 16(10):695-714. PubMed ID: 12269862 [TBL] [Abstract][Full Text] [Related]
29. [Comparative assessment of treatment efficacy with lamotrigine (Lamictal) together with valproate and/or carbamazepine in patients with refractory epilepsy]. Wierzba W; Wajgt A Neurol Neurochir Pol; 1997; 31(6):1133-46. PubMed ID: 9591300 [TBL] [Abstract][Full Text] [Related]
30. Comparison of add-on valproate and primidone in carbamazepine-unresponsive patients with partial epilepsy. Sun MZ; Deckers CL; Liu YX; Wang W Seizure; 2009 Mar; 18(2):90-3. PubMed ID: 18672385 [TBL] [Abstract][Full Text] [Related]
31. Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid. Hillbom M; Tokola R; Kuusela V; Kärkkäinen P; Källi-Lemma L; Pilke A; Kaste M Alcohol; 1989; 6(3):223-6. PubMed ID: 2500138 [TBL] [Abstract][Full Text] [Related]
32. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study. Baulac M; Patten A; Giorgi L Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239 [TBL] [Abstract][Full Text] [Related]
34. A comment on the efficacy of valproate in the treatment of partial seizures. Seino M Epilepsia; 1994; 35 Suppl 5():S101-4. PubMed ID: 8039464 [TBL] [Abstract][Full Text] [Related]
35. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study. Mundlamuri RC; Sinha S; Subbakrishna DK; Prathyusha PV; Nagappa M; Bindu PS; Taly AB; Umamaheswara Rao GS; Satishchandra P Epilepsy Res; 2015 Aug; 114():52-8. PubMed ID: 26088885 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the retention rates between carbamazepine and valproate as an initial monotherapy in Chinese patients with partial seizures: A ten-year follow-up, observational study. Hu Y; Huang Y; Quan F; Hu Y; Lu Y; Wang XF Seizure; 2011 Apr; 20(3):208-13. PubMed ID: 21159526 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study. Trinka E; Ben-Menachem E; Kowacs PA; Elger C; Keller B; Löffler K; Rocha JF; Soares-da-Silva P Epilepsia; 2018 Feb; 59(2):479-491. PubMed ID: 29369348 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191 [TBL] [Abstract][Full Text] [Related]